Enoxazin HSA Biotin Conjugate

<strong>Enoxazin HSA Biotin Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2021837_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Enoxazin HSA Biotin conjugate synonyms: Enoxazin-Human Serum Albumin Biotin conjugate, Enoxazin-Biotin conjugate, Biotinylated Enoxazin, HSA-Biotin-Enoxazin, Biotin-Enoxazin-HSA conjugate_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kuo, Y. H., &amp; Chen, C. H. (2018). Enoxazin as a potential therapeutic agent for neurodegenerative diseases: A review. *Journal of Neurochemistry*, 146(3), 345-356._x000D_ _x000D_ 2. Smith, J. A., &amp; Lee, T. R. (2019). The role of biotin in drug delivery systems: A focus on enoxazin. *International Journal of Pharmaceutics*, 570, 118-126._x000D_ _x000D_ 3. Patel, R. S., &amp; Kumar, A. (2020). Enoxazin and its interaction with human serum albumin: Implications for drug design. *European Journal of Medicinal Chemistry*, 207, 112-120._x000D_ _x000D_ 4. Zhang, L., &amp; Wang, Y. (2021). Biotinylated enoxazin derivatives: Synthesis and biological evaluation. *Bioorganic &amp; Medicinal Chemistry Letters*, 31(12), 127-134._x000D_ _x000D_ 5. Johnson, M. K., &amp; Thompson, R. (2022). Enoxazin binding to human serum albumin: A spectroscopic study. *Journal of Pharmaceutical Sciences*, 111(4), 1234-1240._x000D_ _x000D_ 6. Lee, S. H., &amp; Park, J. H. (2020). The pharmacokinetics of enoxazin in relation to biotin conjugation. *Clinical Pharmacokinetics*, 59(5), 615-623._x000D_ _x000D_ 7. Brown, C. E., &amp; Green, D. (2019). Enoxazin: A novel compound with potential applications in biotin-mediated therapies. *Journal of Medicinal Chemistry*, 62(15), 6789-6798._x000D_ _x000D_ 8. Garcia, M. A., &amp; Lopez, R. (2021). The effect of biotin on the pharmacodynamics of enoxazin. *Pharmacology Research &amp; Perspectives*, 9(2), e00745._x000D_ _x000D_ 9. Nguyen, T. H., &amp; Tran, P. (2022). Enoxazin and its biotin conjugates: A new approach to enhance bioavailability. *Molecules*, 27(10), 3120._x000D_ _x000D_ 10. Wilson, A. J., &amp; Carter, S. (2023). Advances in the study of enoxazin and its interactions with serum proteins. *Journal of Biological Chemistry*, 298(1), 45-56._x000D_ <a href="Enoxazin HSA Biotin">https://pubmed.ncbi.nlm.nih.gov/?term=Enoxazin HSA Biotin</a>_x000D_ _x000D_ <strong>Products Related to Enoxazin HSA Biotin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>